OnCo
companiesCompany

Molecular Partners

aka Molecular Partners AG

Molecular Partners is a Switzerland-based radiopharmaceutical company running 2 late-stage cancer trials of [212Pb]Pb-MP0712 and MP0533 with Obinutuzumab pretreatment in neuroendocrine tumours, non-small-cell lung cancer and pancreatic ductal adenocarcinoma.